Summary
- Current Price
- As of today, COR price is $313.82, up +1.23% on
- Current Price All-Time High
- COR price is currently -16.88% below its historical high of $377.54 set on
- Market Cap
- COR current market cap is $60B, up +4.76% over the past 365 days
- PE Ratio
- COR current PE ratio is 23.33
- Revenue
- COR current annual revenue is $321.33B, up +9.31% year-over-year
- Next Earnings
- The next earnings release for COR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cencora, Inc. |
| Ticker | NYSE: COR |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Country | United States |
| IPO | |
| Indexes | |
| Website | cencora.com |
| Employees | 42,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $313.82 | |
| Price, 1D Change | +1.23% | |
| Market Cap | $60B | |
| TTM Dividend Yield | 0.76% | |
| PE Ratio | 23.33 | |
| Beta | -0.22 | |
| Revenue | $321.33B | |
| Revenue, 1Y Change | +9.31% | |
| EPS | $7.96 | |
| EPS, 1Y Change | +5.66% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.60 | |
| Next Ex-Dividend | $0.60 | |
| Last Split | 10:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ABC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $7.96 | |
| EPS Estimate | $17.85 | |
| EPS Est. Change | +124.17% | |
| Revenue | $321.33B | |
| Revenue Estimate | $337.01B | |
| Revenue Est. Change | +4.88% | |
| Current Price | $313.82 | |
| Price Target | $365.00 | - |
| Price Tgt. Change | +16.31% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.65 | $7.53 | -44.80% | |
| $15.94 | $7.96 | -50.06% | |
| $17.85 | N/A | +124.17% | |
| $19.83 | N/A | +149.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $292.66B | $293.96B | +0.45% | |
| $320.99B | $321.33B | +0.11% | |
| $337.01B | N/A | +4.88% | |
| $356.15B | N/A | +10.83% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +6.43% | |
| Price, 3Y | +67.25% | |
| Market Cap, 1Y | +4.76% | |
| Market Cap, 3Y | +57.92% | |
| Revenue, 1Y | +9.31% | |
| Revenue, 3Y | +34.68% | |
| EPS, 1Y | +5.66% | |
| EPS, 3Y | -1.02% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $313.82 | |
| SMA 200 | $324.09 | |
| SMA 50 | $298.47 | |
| EMA 200 | $308.22 | |
| EMA 50 | $304.44 | |
| MACD | $5.34 | |
| Beta | -0.22 | |
| ATR | $9.42 | |
| 14-Day RSI | 52.38 | |
| 10-Day Volatility | 44.10% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.60 | |
| Upcoming | $0.60 | |
| Dividend Yield | 0.70% | |
| Total Dividend | $2.20 | |
| $437.08M | ||
| 27.88% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $321.33B | |
| EPS | $7.96 | |
| Gross Profit | $10.43B | |
| Gross Margin | 3.25% | |
| Operating Income | $3.93B | |
| Operating Margin | 1.22% | |
| Net Income | $1.57B | |
| Net Margin | 0.49% | |
| EBITDA | $4.98B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 4.38 | |
| 0.90 | ||
| 0.52 | ||
| - | ||
| 6 | ||
| 4.88 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 23.33 | |
| 0.18 | ||
| 19.63 | ||
| 12.59 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $1.51B | |
| $4.39B | ||
| $76.59B | ||
| $52.24B | ||
| $74.84B | ||
| $57.82B | ||
| Total Debt | $9.33B | |
| $371.56M | ||
| $54.72B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $319.78B | ||
| $6.49B | ||
| $310.91B | ||
| $0.00 | ||
| $1.06B | ||
| $0.00 | ||
| $690.52M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $3.88B | ||
| -$4.98B | ||
| $2.25B | ||
| Capex | $667.98M | |
| $3.21B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | → | |
| JP Morgan | → | |
| UBS | → | |
| Evercore ISI Group | → | |
| B of A Securities | → | |
| Barclays | → | |
| Wells Fargo | → | |
| UBS | → | |
| Evercore ISI Group | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with COR
FAQ
- What is the ticker symbol for Cencora, Inc.?
- The ticker symbol for Cencora, Inc. is NYSE:COR
- Does Cencora, Inc. pay dividends?
- Yes, Cencora, Inc. pays dividends. The last payment was $0.60, with an ex-dividend date on May 15, 2026
- What sector is Cencora, Inc. in?
- Cencora, Inc. is in the Healthcare sector
- What industry is Cencora, Inc. in?
- Cencora, Inc. is in the Medical Distribution industry
- What country is Cencora, Inc. based in?
- Cencora, Inc. is headquartered in United States
- When did Cencora, Inc. go public?
- Cencora, Inc. initial public offering (IPO) was on April 4, 1995
- Is Cencora, Inc. in the S&P 500?
- Yes, Cencora, Inc. is included in the S&P 500 index
- Is Cencora, Inc. in the NASDAQ 100?
- No, Cencora, Inc. is not included in the NASDAQ 100 index
- Is Cencora, Inc. in the Dow Jones?
- No, Cencora, Inc. is not included in the Dow Jones index
- When was Cencora, Inc. last earnings report?
- Cencora, Inc.'s most recent earnings report was on August 5, 2026
- When does Cencora, Inc. report earnings?
- The next expected earnings date for Cencora, Inc. is November 4, 2026
Data Sources & References
- COR Official Website www.cencora.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1140859/000114085925000131/0001140859-25-000131-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- COR Profile on Yahoo Finance finance.yahoo.com/quote/COR
- COR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cor
